Prevalence, Incidence, and Factor Concentrate Usage Trends of Hemophiliacs in Taiwan

Abstract

PurposeHemophilia A and B (HA, HB) are the most common X-linked inherited bleeding disorders. The introduction of factor concentrates has allowed for control of the lifelong chronic disease. However, no studies have been published regarding the epidemiology of hemophilia in Taiwan. Our aim was to determine the prevalence, incidence, and mortality rate, as well as trends in the use of factor concentrates, in individuals with hemophilia in Taiwan.Materials and MethodsA retrospective study was conducted using the National Health Insurance Research Database between 1997 and 2007.ResultsWe identified 988 males with hemophilia (HA : HB ratio=5.4 : 1). The mean prevalence per 100000 males was 6.7±0.1 for HA and 1.2±0.1 for HB. The estimated mean annual incidence per live male birth was 1 in 10752 for HA and 1 in 47619 for HB. Standardized mortality ratios for males with hemophilia (all severities) or severe hemophilia were 1.3- and 2.1-fold higher than that of the general male population, respectively. Mean factor VIII (FVIII) and factor IX (FIX) usage was 1.5003±0.4029 and 0.3126±0.0904 international units (IUs) per capita, respectively. Mean FVIII and FIX usage per patient with hemophilia (all severities) or severe hemophilia was 44027±11532 and 72341±17298, respectively, and 49407±13015 and 74369±18411 IUs per person with HA or HB, respectively.ConclusionOur data revealed epidemiologic and factor concentrate usage trends in males with hemophilia in Taiwan, highlighting a need for improvements in the mandatory National Health Insurance registry. A better-designed, patient-centered registry system would enable more detailed patient information collection and analysis, improving subsequent care.

An overview of patients with haemophilia A in China: Epidemiology, disease severity and treatment strategies

“…A provincial registry‐based study by Zhao et al analysed the clinical features of haemophilia patients from 11 Hemophilia Treatment Centers (HTC) in Shanxi province (January 2010 to December 2013) and reported that 175 (50%) of 348 patients with haemophilia A had severe disease 9 . A retrospective study by Tu et al using the National Health Insurance Research Database (1997 and 2007) in Taiwan, China, reported that among 833 patients with haemophilia A, 57.6% had severe disease 10 . Au et al reported that among 92 patients with haemophilia A identified by the Hospital Authority in Hong Kong, 42% had severe disease 11 .…”

Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients

“…The demands of blood products transfusion vary, which depended on individual disease characteristics and disease severities [ 43 , 44 ]. In general, thalassemic patients receive packed red blood cell transfusion at the interval of every 2–4 weeks.…”

Risk of major comorbidities among workers with hemophilia

“…The prevalence, incidence, factors usage, and mortality of PWH in Taiwan were discussed in previous studies. [ 11 , 12 ] In this study, we investigated the effect of employment on the health status of PWH compared with a matched general population.…”